Pharmaceutical Industry Relies on Medical Science Liaisons to Generate Value Across Diverse Customer Groups

CHAPEL HILL, N.C., June 1, 2012 /PRNewswire/ -- Medical Science Liaisons build relationships between the pharmaceutical industry and key stakeholders in the marketplace.

In recent years, the role of Medical Science Liaisons (MSLs) has expanded across a diverse set of customers that now include regional thought leaders, important clinical investigators, local opinion leaders, payers and government thought leaders. In the face of these growing responsibilities, many biopharmaceutical and medical device companies are finding it increasingly challenging for their MSL groups to deliver exceptional services.

In addition, concerns about compliance and legal limitations are forcing companies to re-examine how their MSLs and internal medical staff can work together to build strong relationships with key customer groups and decision-makers.

Given the expanding role of MSL groups and the challenging environment they face, research and consulting firm Best Practices, LLC has conducted a comprehensive research study of the structure, management and services that are hallmarks of successful MSL groups.

"Medical Science Liaison Services Excellence: Generating Value for Diverse Customer Groups" explores how biopharma companies deliver exceptional MSL Services to various customer groups and stakeholders in an increasingly challenging business environment. The research also examined best practices in MSL management and creating value for diverse customer groups that include physicians, patients, payers, policy makers and advocates.

Study objectives included:

• Explore the methods used by MSLs to serve stakeholders and build those stakeholder relationships.
• Identify roles, responsibilities and service levels provided to Key Opinion Leaders (KOLs).
• Explore the ways through which MSLs provide services to KOLs. Determine frequency of services during pre- and post-approval stages.

This study is based on research and information provided by 35 pharmaceutical and medical device executives from 30 companies. The 145-page report provides two segments: the total benchmark class and U.S. only.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1158.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. For more information about Best Practices, LLC visit our Web site at www.best-in-class.com.

SOURCE Best Practices, LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED